Rapid identification of gram-negative bacteria with and without CTX-M extended-spectrum β-lactamase from positive blood culture bottles by PCR followed by microchip gel electrophoresis

Journal of Clinical Microbiology

Volumn 49, Issue 4, 2011, Pages 1483-1488

  Fujita, Shin Ichi ^a   Yosizaki, Kentaro ^a   Ogushi, Thikako ^b   Uechi, Kouhei ^b   Takemori, Yukiko ^b   Senda, Yasuko ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE CTX M; BETA LACTAMASE SHV; BETA LACTAMASE TEM; EXTENDED SPECTRUM BETA LACTAMASE; INTERNAL TRANSCRIBED SPACER; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOOD CULTURE; CONTROLLED STUDY; COST; GEL ELECTROPHORESIS; GENE AMPLIFICATION; GENETIC POLYMORPHISM; GRAM NEGATIVE BACTERIUM; MICROCHIP GEL ELECTROPHORESIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA GENE; SEQUENCE ANALYSIS;

BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; BETA-LACTAMASES; BLOOD; DNA, BACTERIAL; DNA, RIBOSOMAL SPACER; ELECTROPHORESIS; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

BACTERIA (MICROORGANISMS); ENTEROBACTER; ESCHERICHIA COLI; KLEBSIELLA OXYTOCA; NEGIBACTERIA;

EID: 79953884634     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01976-10     Document Type: Article

References (26)

1. al Naiemi, N., B. Duim, and A. Bart. 2006. A CTX-M extended-spectruM β-lactamase in Pseudomonas aeruginosa and Stenotrophomonas maltophilia. J. Med. Microbiol. 55:1607-1608. (Pubitemid 44713882)
2. al Naiemi, N., et al. 2005. Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology. J. Clin. Microbiol. 43:4862-4864. (Pubitemid 41298296)
3. Barenfanger, J., C. Drake, and G. Kacich. 1999. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J. Clin. Microbiol. 37:1415-1418. (Pubitemid 29187810)
4. Canton, R., and T. M. Coque. 2006. The CTX-M β-lactamase pandemic. Curr. Opin. Microbiol. 9:466-475.
5. Cartwright, C. P., F. Stock, S. E. Beekmann, E. C. Williams, and V. J. Gill. 1995. PCR amplification of rRNA intergenic spacer regions as a method for epidemiologic typing of Clostridium difficile. J. Clin. Microbiol. 33:184-187. (Pubitemid 24382423)
6. Cheng, J., et al. 1998. Degenerate oligonucleotide primed-polymerase chain reaction and capillary electrophoretic analysis of human DNA on microchipbased devices. Anal. Biochem. 257:101-106. (Pubitemid 28128970)
7. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing; 15th information supplement. CLSI M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Eigner, U., M. Weizenegger, A.-M. Fahr, and W. Witte. 2005. Evaluation of a rapid direct assay for identification of bacteria and the mecA and van genes from positive blood cultures. J. Clin. Microbiol. 43:5256-5262. (Pubitemid 41484034)
9. Fujita, S., Y. Senda, T. Iwagami, and T. Hashimoto. 2005. Rapid identification of staphylococcal strains from positive-testing blood culture bottles by internal transcribed spacer PCR followed by microchip gel electrophoresis. J. Clin. Microbiol. 43:1149-1157. (Pubitemid 40364931)
10. Goossens, H., and B. Grabein. 2005. Prevalence and antimicrobial susceptibility data for extended-spectruM β-lactamase- and AmpC-producing Enterobacteraceae from the MYSTIC program in Europe and the United States (1997-2004). Diagn. Microbiol. Infect. Dis. 53:257-264. (Pubitemid 41796896)
11. Gürtler, V., and V. A. Stanisich. 1996. New approaches to typing and identification of bacteria using the 16S-23S rDNA spacer region. Microbiology 142:3-16. (Pubitemid 26032041)
12. Hawser, S. P., et al. 2009. Emergence of high levels of extended-spectrum-β-lactamase-producing Gram-negative bacilli in the Asia-Pacific region: data from the study for monitoring antimicrobial resistance trends (SMART) program, 2007. Antimicrob. Agents Chemother. 53:3280-3284.
13. Ho, P. L., W. M. Chan, K. W. Tsang, S. S. Wong, and K. Young. 2002. Bacteremia caused by Escherichia coli producing extended-spectrum betalactamase: a case-control study of risk factors and outcomes. Scand. J. Infect. Dis. 34:567-573. (Pubitemid 35012337)
14. Jensen, M. A., J. A. Webster, and N. Straus. 1993. Rapid identification of bacteria on the basis of polymerase chain reaction-amplified ribosomal DNA spacer polymorphisms. Appl. Environ. Microbiol. 59:945-952. (Pubitemid 23096626)
15. Jordan, J. A. J. Jones-Laughner, and M. B. Durso. 2009. Utility of pyrosequencing in identifying bacteria directly from positive blood culture bottles. J. Clin. Microbiol. 47:368-372.
16. Lewis, I. I., J. S. M. Herrera, B. Wickes, J. E. Patterson, and J. H. Jorgensen. 2007. First report of the emergence of CTX-M-type extended-spectruM β-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob. Agents Chemother. 51:4015-4021. (Pubitemid 350057800)
17. Marlowe, E. M., et al. 2003. Application of an rRNA probe matrix for rapid identification of bacteria and fungi from routine blood cultures. J. Clin. Microbiol. 41:5127-5133. (Pubitemid 37429926)
18. Monstein, H.-J., et al. 2007. Multiplex PCR amplification assay for the detection of blaSHV, blaTEM and blaCTX-M genes in Enterobacteriaceae. APMIS 115:1400-1408.
19. Munson, E. L., D. J. Diekema, S. E. Beekmann, K. C. Chapin, and G. V. Doern. 2003. Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. J. Clin. Microbiol. 41:495-497. (Pubitemid 36098632)
20. Paterson, D. L., and R. A. Bonomo. 2005. Extended-spectruM β-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686.
21. Peters, R. P. H., et al. 2006. Faster identification of pathogens in positive blood cultures by fluorescence in situ hybridization in routine practice. J. Clin. Microbiol. 44:119-123. (Pubitemid 43100589)
22. Schiappa, D. A., et al. 1996. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J. Infect. Dis. 174:529-536. (Pubitemid 26299686)
23. Suzuki, S., et al. 2009. Changes in the prevalence of extended-spectruM β-lactamase-producing Escherichia coli in Japan by clonal spread. J. Antimicrob. Chemother. 63:72-79.
24. Tumbarello, M., et al. 2007. Predictors of mortality in patients with bloodstream infections caused by extended-spectruM β-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob. Agents Chemother. 51:1987-1994. (Pubitemid 46903084)
25. Turenne, C. Y., S. E. Sanche, D. J. Hoban, J. A. Karlowsky, and A. M. Kabani. 1999. Rapid identification of fungi by using the internal transcribed spacer 2 genetic region and an automated fluorescent capillary electrophoresis system. J. Clin. Microbiol. 37:1846-1851. (Pubitemid 29235234)
26. Wisplinghoff, H., et al. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317. (Pubitemid 39050477)